SCHEMBL30120984

SCHEMBL30120984

N=C(N)NCCC[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 7/20 0.40
▸ NPY5R Q15761 7/20 0.40
▸ NPY1R P25929 6/20 0.40
▸ NPY2R P49146 4/20 0.40
▸ QRFPR Q96P65 1/20 0.39
▸ TFPI P10646 1/20 0.38
▸ SLC15A2 Q16348 1/20 0.37
▸ NOD1 Q9Y239 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.36
▸ NMT2 O60551 1/20 0.35
▸ NMT1 P30419 1/20 0.35
▸ C3AR1 Q16581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30121052 1.00 NPY4R (0.40) NPY4RNPY5RNPY1RNPY2RQRFPR
SCHEMBL29482452 0.94 NPY4R (0.43) NPY4RNPY5RNPY1RNPY2RSLC15A2
SCHEMBL30120973 0.94 NPY4R (0.43) NPY4RNPY5RNPY1RNPY2RSLC15A2
SCHEMBL29875551 0.92 C3AR1 (0.40) NPY4RNPY5RNPY1RNPY2RQRFPR
SCHEMBL31670642 0.91 GNPAT (0.41) NPY4RNPY5RNPY1RNPY2RQRFPR
SCHEMBL29736266 0.90 SLC15A2 (0.47) NPY4RNPY5RNPY1RNPY2RSLC15A2
SCHEMBL30562993 0.90 SLC15A2 (0.47) NPY4RNPY5RNPY1RNPY2RSLC15A2
SCHEMBL29712681 0.90 SLC15A2 (0.47) NPY4RNPY5RNPY1RNPY2RSLC15A2
SCHEMBL17930107 0.90 SLC15A2 (0.47) NPY4RNPY5RNPY1RNPY2RQRFPR
SCHEMBL29614393 0.90 SLC15A2 (0.47) NPY4RNPY5RNPY1RNPY2RSLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4314016-A1 CYCLIC CELL PENETRATING PEPTIDES Entrada Therapeutics, Inc. (US) 2024-02-07 — — EP claimed
WO-2022213118-A1 CYCLIC CELL PENETRATING PEPTIDES ENTRADA THERAPEUTICS, INC. (US) 2022-10-06 — — WO claimed
Send feedback